Connect Biopharma Holdings Ratios (2023-2025) | CNTB

Ratios Jun2023 Dec2023 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin -1,051.60%-1,260.74%-26,758.33%-107,118.75%
EBIT Margin -1,135.85%-1,378.08%-27,966.67%-110,481.25%
EBITDA Margin -1,009.52%-1,431.23%-26,393.75%-106,887.50%
Operating Margin -1,135.85%-1,378.08%-27,966.67%-110,481.25%
Net Margin -1,056.28%-1,275.93%-26,872.92%-107,500.00%
FCF Margin -1,079.08%-377.08%-26,862.50%-109,000.00%
Efficiency
Assets Average 135.73M96.98M87.70M75.04M
Equity Average 115.08M87.53M77.12M63.36M
Invested Capital 128.66M101.50M110.48M92.17M82.90M71.34M55.37M
Asset Utilization Ratio 0.020.020.01
Leverage & Solvency
Equity Ratio 0.890.800.920.910.890.860.82
Valuation
Enterprise Value -81.61M-118.30M-110.17M-93.73M-84.01M-71.77M-54.78M
Return Ratios
Return on Sales -10.56%-12.76%-8.98%-268.73%-1,075.00%
Return on Capital Employed -0.24%-0.63%-0.82%
Return on Invested Capital -0.25%-0.63%-0.83%
Return on Assets -0.18%-0.51%-0.66%
Return on Equity -0.20%-0.58%-0.78%